Cargando…
Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation
OBJECTIVE: We performed a clinical, functional, and pharmacologic characterization of the novel p.P1158L Nav1.4 mutation identified in a young girl presenting a severe myotonic phenotype. METHODS: Wild-type hNav1.4 channel and P1158L mutant were expressed in tsA201 cells for functional and pharmacol...
Autores principales: | Desaphy, Jean-François, Carbonara, Roberta, D'Amico, Adele, Modoni, Anna, Roussel, Julien, Imbrici, Paola, Pagliarani, Serena, Lucchiari, Sabrina, Lo Monaco, Mauro, Conte Camerino, Diana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891212/ https://www.ncbi.nlm.nih.gov/pubmed/27164696 http://dx.doi.org/10.1212/WNL.0000000000002721 |
Ejemplares similares
-
Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy
por: Desaphy, Jean-François, et al.
Publicado: (2012) -
Long-Term Safety and Usefulness of Mexiletine in a Large Cohort of Patients Affected by Non-dystrophic Myotonias
por: Modoni, Anna, et al.
Publicado: (2020) -
Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes()
por: Desaphy, Jean-François, et al.
Publicado: (2013) -
In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia
por: Desaphy, Jean-François, et al.
Publicado: (2013) -
Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs
por: Desaphy, Jean-François, et al.
Publicado: (2014)